India Pharma Award 2022
TCS ADD™ Connected Clinical Trial platform received recognition for providing a unified, next-gen patient and site-centric offering
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
Our expert, committed team put our shared values into action – every day. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
Modern. Scalable. Adaptive. Modular.
Matthew Moyer, Director of Operations and Supply Tech, Merck, and Narayanan R., Chief Architect, TCS ADD™ Platforms, discuss and demonstrate approaches and real-life examples to enable patient-centric trials through a unified, integrated platform.
You have these already downloaded
We have sent you a copy of the report to your email again.
TCS ADD™ Connected Clinical Trial platform received recognition for providing a unified, next-gen patient and site-centric offering
Improved data quality and oversight
Quicker decision-making
Meaningful insights and preventive intervention
Faster drug registration process
Pharma organizations need to enable informed, engaged, and connected clinical trials that are patient-centric and site-friendly.
The siloed, convoluted, and cumbersome clinical trial processes levied immense operational burdens on sites, sponsors, and CROs, thus preventing them from executing trials effectively. Disparate systems have resulted in manual, paper-based, time-consuming, and error-prone processes resulting in delayed trial timelines.
TCS ADD™ Connected Clinical Trials provides a unified interface for patients and sites and incorporates smart, intuitive, futuristic, cloud-based technologies and collaborations to enable next-generation patient-centric trials.
14+ Patents | 19+ Global customers | 700+ Trials supported | 50K+ Sites onboarded | 100% Regulatory compliant |
TCS helped Roche roll out an eConsent solution
An industry-first unified platform for clinical supply management that brings together kit tracking, unit dose tracking, and digital labels supporting direct-to-patient and traditional supply models.
Highly configurable solution with a rich library of personalized and multimedia engagement tools
Secure, end-to-end consent solution supporting paper-based and e-signature; embedded with multimedia engagement tools
Device-agnostic, seamless, multi-tenant, and feature-rich televisit functionality for patients, sites, and sponsors
Biometric sensors with connected medical devices for timely and accurate health insights through automated data collection and remote monitoring
Personalized patient and site support throughout the trial process via portals, apps, and multimedia literature
Swipe LeftSwipe RightModern technologies, deep contextual expertise, and close collaboration with pharma organizations, patient advocacy groups, regulatory bodies, clinicians, and others alike combined with an ability to support adaptive (virtual, traditional, and hybrid) studies make TCS ADD™ Connected Clinical Trials, our decentralized trials platform, a preferred choice for trials worldwide.
Rachna Malik
Global Head, TCS ADD™ Platforms
Learn how we can help you bring drugs to the market faster.
Request for Demo